Акушерство и Гинекология Санкт-Петербурга. 2018; : 70-74
Аденомиоз как самостоятельное заболевание (обзор литературы)
Аннотация
Аденомиоз – заболевание с совершенно особой эпидемиологией и клинической картиной. Информативность и чувствительность УЗИ и МРТ делает их методами исследования, достаточными для постановки данного диагноза. Диапазон частоты встречаемости АМ по разным авторам от 1% до 88%. При этом далеко не у всех пациенток наблюдаются выраженные симптомы заболевания. Максимально широкая трактовка вариантов нормы позволяет избежать гипердиагностики. Аденомиоз возникает из базального слоя функционирующего эндометрия. Рост и патологическую инвагинацию базального слоя эндометрия в миометрий провоцируют различные гормональные, экологические и биологические факторы. Вопрос непосредственного влияния аденомиоза на снижение фертильности остается открытым. Однако все больше исследователей рассматривает аденомиоз как фактор риска бесплодия. Малигнизация аденомиоза – явление редкое.
Список литературы
1. Haney A.F. Modern Approaches to Endometriosis. Eds E. Thomas, J. Rock. London; 1991. V. 3: 19.
2. Линде В.А., Татарова Н.А. Эндометриозы. М.: ГЭОТАР-Медицина; 2010. 192 с.
3. Адамян Л.В., Кулаков В.И., Андреева Е.Н. Эндометриозы. М.: Медицина; 2006. 416 с.
4. Tapmeier T.T., Becker M.K. A pale way to understand adenomyosis? Fertility and sterility. 2015; 104 (6): 1378–1378.
5. Haney A.F. Endometriosis, macrophages and adhesions. Prod. Clin. Biol. Res. 1993; 381: 19–44.
6. Xiaoyu L., Weiyuan Z., Ping J. et al. Serum differential proteomics analysis of endometriosis and adenomyosis by iTRAQ technique. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2014; 182: 62–65.
7. Leyendecker G., Bilgicyildirim L., Inacker M. et al. Adenomyosis and en-dometriosis. Re-examination of their association to obtain a more complete understanding of the mechanisms of automatic trauma. MRI study. Arch. Gynecol.Obstet. 2015; 291 (4): 917–32.
8. Benadiano G., Brosens I., Habib M. Adenomyosis: the approach from the point of view of the life cycle. Reproductive Biomedicine. 2015; 30 (3): 220–232.
9. Баскаков В.П., Цвелев Ю.В., Кира Е.Ф. Эндометриоидная болезнь. СПб.: ООО «Издательство Н-Л»; 2002. 452 с.
10. Struble J., Ryd S., Bedaiwy M.A. Adenomyosis: Clinical Overview. Journal of Minimally Invasive Gynecology. 2016; 23 (2): 164–185.
11. Barrier B. Клинический случай: выявление аденомиоза у самок шимпанзе – первое сообщение в литературе: Обзор статей Human Reprod (2007; 22: 6). Проблемы репродукции. 2007; 5: 123.
12. Рухляда Н.Н. Диагностика и лечение манифестного аденомиоза. СПб.: ЭЛБИ-СПб; 2004. 205 с.
13. Адамян Л.В., Андреева Е.Н., Беженарь В.Ф. и др. Эндометриоз: диагностика, лечение и реабилитация. М.; 2013. 58 с.
14. Pinzauti S., Lazzeri L., Tosti C. et al. Transvaginal echographic signs of diffuse adenomyosis in 18–30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015; 46 (6): 730–6.
15. Vercellini P., Cjnsonni D., Giussy B. et al. Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: a systematic review and meta-analysis. Reproductive Biomedicine. 2014; 28 (6): 704–713.
16. Линде В.А., Волков Н.Н., Добровольский М.С., Иванов А.В. Миома матки и миомэктомия. М.: SweetGroup; 2010. 94 с.
17. Di Donato N., Montanari G., Benfenati A.et al. Prevalence of adenomyosis in women who underwent endometriosis surgery. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2014; 181: 289–293.
18. Адамян Л.В., Андреева Е.Н., Аполихина И.А. и др. Сочетанные доброкачественные опухоли и гиперпластические процессы матки (миома, аденомиоз, гиперплазия эндометрия). М.; 2015. 92 с.
19. Савицкий Г.А., Савицкий А.Г. Что такое миома матки? СПб.: ЭЛБИ-СПб; 2016. 216 с.
20. Benaglia L., Cardellicchio L., Leonardi M. Asymptomatic adenomyosis and embryo implantation in IVF cycles. Reproductive Biomedicine. 2014; 29 (5): 606–611.
21. Khan K.N., Kitajima M., Hiraki K. et al. Participation factor-induced epithelialmesenchymal transition of human hepatocyte growth in adenomyosis. Biol. Reprod. 2015; 92 (2): 35.
22. Liu X., Shen M., Qi Q., Zhang H., Guo S.W. Proof of the epithelial-mesenchymal transition induced by tromobtsites of fibroblasts with transdifferentiation into myofibroblasts in the development of adenomyosis. Hum. Reprod. 2016; 31 (4): 734–49.
23. Jiang J.F., Sun A.J., Xue W. et al. Aberrant expressed long non-coding RNA in the eutopic endometrium of patients with myoma adenomyosis. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2016; 199: 32–37.
24. Czin V., Dan X., Yang Y. et al. Expression of Grim-19 in the foci of adenomyosis and its possible role in the pathogenesis of the disease. Fertility and sterility. 2016; 105 (4): 1093–1101.
25. Yi G.-W., Kim S.H., Jin H. et al. Increase in expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells. Fertility and sterility. 2015; 103 (4): 1089–1097.
26. Shang W.Q., Yu J.J., Zhu L. et al. Blocking of IL-22, a potential strategy for the treatment of adenomyosis by inhibiting crosstalk between the vasoendothelial and endometrial stromal cells. Am. J. Transl. Res. 2015; 7 (10): 1782–97.
27. Van S., Duan H., Zhang Y., Sun F.Q. Abnormal activation of RhoA / ROCK-I Signaling in the Junctional zone of smooth muscle cells in patients with Adenomyosis. Reprod Sci. 2016; 23 (3): 333–41.
28. Shutders I., Santulli P., Chouzenoux S. et al. Activation of MAPK / ERK Cell by a signal cascade in the uterine cells of smooth muscles of women with Adenomyosis. Reprod Sci. 2015; 22 (12): 1549–60.
29. Адамян Л.В., Андреева Е.Н., Артымук Н.В. и др. Миома матки: диагностика, лечение и реабилитация. М.; 2015. 100 с.
30. Беженарь В.Ф., Комличенко Э.В., Ярмолинская М.И. и др. Инновационные подходы к восстановлению репродуктивной функции у больных с миомой матки. Акушерство и гинекология. 2016; 1: 80–87.
31. Блинов Д.С., Грачева Т.С., Исламова М.Н., Чугунова Л.А. Проблемы репродуктивного здоровья женщин и способы повышения репродуктивного потенциала [Электронный ресурс] // Огарев-online. 2016, 15.
32. Радзинский В.Е., Пустотина О.А. Планирование семьи в XXI веке. М.: ГЭОТАР-Медиа; 2015. 256 с.
33. Garawaglia E., Audrey S., Annalisa J., Stefano F., et al. Adenomyosis and its effect on fertility women. Iran J Med Reprod. 2015; 13 (6): 327–336.
34. Matsuo K., Kaun S.S., Gualtieri M. et al. The importance of adenomyosis on a tumor progression and the outcome of the survival of endometrial cancer. Ann. Surg.oncol. 2014; 21 (13): 4246–55.
35. Koshiyama M., Suzuki A., Ozava M. et al. Adenocarcinomas arising from uterine adenomyosis: a report of four cases. Inter J Gynecol Pathol. 2002; 21 (3): 239–245.
36. Kok V.C., Tsai H.J., Su C.F., Li C.K. Risks for ovaries, endometrium, breast, colorectal and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population study. Int. J. Gynecol. Cancer. 2015; 25 (6): 968–76.
Obstetrics and Gynaecology of Saint-Petersburg. 2018; : 70-74
Adenomyosis as an independent disease (literature review)
Abstract
Adenomyosis is a disease with a very special epidemiology and clinical picture. The informativeness and sensitivity of the ultrasound and MRI makes, them the methods of research sufficient for the diagnosis. The frequency range of the occurrence of AM by different authors from 1% to 88%. However, not all patients have pronounced symptoms of disease. The widest possible interpretation of the standard variants allows to avoid overdiagnosis. Adenomyosis arises from the basal layer of the functioning endometrium. The growth and pathological invagination of the basal layer of endometrium in the myometrium provoke various hormonal, ecological and biological factors. The question of the direct effect of adenomyosis on fertility is still open. However, more and more researchers are looking at adenomyosis as a risk factor for infertility. Malignancy of adenomyosis is a rare phenomenon.
References
1. Haney A.F. Modern Approaches to Endometriosis. Eds E. Thomas, J. Rock. London; 1991. V. 3: 19.
2. Linde V.A., Tatarova N.A. Endometriozy. M.: GEOTAR-Meditsina; 2010. 192 s.
3. Adamyan L.V., Kulakov V.I., Andreeva E.N. Endometriozy. M.: Meditsina; 2006. 416 s.
4. Tapmeier T.T., Becker M.K. A pale way to understand adenomyosis? Fertility and sterility. 2015; 104 (6): 1378–1378.
5. Haney A.F. Endometriosis, macrophages and adhesions. Prod. Clin. Biol. Res. 1993; 381: 19–44.
6. Xiaoyu L., Weiyuan Z., Ping J. et al. Serum differential proteomics analysis of endometriosis and adenomyosis by iTRAQ technique. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2014; 182: 62–65.
7. Leyendecker G., Bilgicyildirim L., Inacker M. et al. Adenomyosis and en-dometriosis. Re-examination of their association to obtain a more complete understanding of the mechanisms of automatic trauma. MRI study. Arch. Gynecol.Obstet. 2015; 291 (4): 917–32.
8. Benadiano G., Brosens I., Habib M. Adenomyosis: the approach from the point of view of the life cycle. Reproductive Biomedicine. 2015; 30 (3): 220–232.
9. Baskakov V.P., Tsvelev Yu.V., Kira E.F. Endometrioidnaya bolezn'. SPb.: OOO «Izdatel'stvo N-L»; 2002. 452 s.
10. Struble J., Ryd S., Bedaiwy M.A. Adenomyosis: Clinical Overview. Journal of Minimally Invasive Gynecology. 2016; 23 (2): 164–185.
11. Barrier B. Klinicheskii sluchai: vyyavlenie adenomioza u samok shimpanze – pervoe soobshchenie v literature: Obzor statei Human Reprod (2007; 22: 6). Problemy reproduktsii. 2007; 5: 123.
12. Rukhlyada N.N. Diagnostika i lechenie manifestnogo adenomioza. SPb.: ELBI-SPb; 2004. 205 s.
13. Adamyan L.V., Andreeva E.N., Bezhenar' V.F. i dr. Endometrioz: diagnostika, lechenie i reabilitatsiya. M.; 2013. 58 s.
14. Pinzauti S., Lazzeri L., Tosti C. et al. Transvaginal echographic signs of diffuse adenomyosis in 18–30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015; 46 (6): 730–6.
15. Vercellini P., Cjnsonni D., Giussy B. et al. Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: a systematic review and meta-analysis. Reproductive Biomedicine. 2014; 28 (6): 704–713.
16. Linde V.A., Volkov N.N., Dobrovol'skii M.S., Ivanov A.V. Mioma matki i miomektomiya. M.: SweetGroup; 2010. 94 s.
17. Di Donato N., Montanari G., Benfenati A.et al. Prevalence of adenomyosis in women who underwent endometriosis surgery. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2014; 181: 289–293.
18. Adamyan L.V., Andreeva E.N., Apolikhina I.A. i dr. Sochetannye dobrokachestvennye opukholi i giperplasticheskie protsessy matki (mioma, adenomioz, giperplaziya endometriya). M.; 2015. 92 s.
19. Savitskii G.A., Savitskii A.G. Chto takoe mioma matki? SPb.: ELBI-SPb; 2016. 216 s.
20. Benaglia L., Cardellicchio L., Leonardi M. Asymptomatic adenomyosis and embryo implantation in IVF cycles. Reproductive Biomedicine. 2014; 29 (5): 606–611.
21. Khan K.N., Kitajima M., Hiraki K. et al. Participation factor-induced epithelialmesenchymal transition of human hepatocyte growth in adenomyosis. Biol. Reprod. 2015; 92 (2): 35.
22. Liu X., Shen M., Qi Q., Zhang H., Guo S.W. Proof of the epithelial-mesenchymal transition induced by tromobtsites of fibroblasts with transdifferentiation into myofibroblasts in the development of adenomyosis. Hum. Reprod. 2016; 31 (4): 734–49.
23. Jiang J.F., Sun A.J., Xue W. et al. Aberrant expressed long non-coding RNA in the eutopic endometrium of patients with myoma adenomyosis. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2016; 199: 32–37.
24. Czin V., Dan X., Yang Y. et al. Expression of Grim-19 in the foci of adenomyosis and its possible role in the pathogenesis of the disease. Fertility and sterility. 2016; 105 (4): 1093–1101.
25. Yi G.-W., Kim S.H., Jin H. et al. Increase in expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells. Fertility and sterility. 2015; 103 (4): 1089–1097.
26. Shang W.Q., Yu J.J., Zhu L. et al. Blocking of IL-22, a potential strategy for the treatment of adenomyosis by inhibiting crosstalk between the vasoendothelial and endometrial stromal cells. Am. J. Transl. Res. 2015; 7 (10): 1782–97.
27. Van S., Duan H., Zhang Y., Sun F.Q. Abnormal activation of RhoA / ROCK-I Signaling in the Junctional zone of smooth muscle cells in patients with Adenomyosis. Reprod Sci. 2016; 23 (3): 333–41.
28. Shutders I., Santulli P., Chouzenoux S. et al. Activation of MAPK / ERK Cell by a signal cascade in the uterine cells of smooth muscles of women with Adenomyosis. Reprod Sci. 2015; 22 (12): 1549–60.
29. Adamyan L.V., Andreeva E.N., Artymuk N.V. i dr. Mioma matki: diagnostika, lechenie i reabilitatsiya. M.; 2015. 100 s.
30. Bezhenar' V.F., Komlichenko E.V., Yarmolinskaya M.I. i dr. Innovatsionnye podkhody k vosstanovleniyu reproduktivnoi funktsii u bol'nykh s miomoi matki. Akusherstvo i ginekologiya. 2016; 1: 80–87.
31. Blinov D.S., Gracheva T.S., Islamova M.N., Chugunova L.A. Problemy reproduktivnogo zdorov'ya zhenshchin i sposoby povysheniya reproduktivnogo potentsiala [Elektronnyi resurs] // Ogarev-online. 2016, 15.
32. Radzinskii V.E., Pustotina O.A. Planirovanie sem'i v XXI veke. M.: GEOTAR-Media; 2015. 256 s.
33. Garawaglia E., Audrey S., Annalisa J., Stefano F., et al. Adenomyosis and its effect on fertility women. Iran J Med Reprod. 2015; 13 (6): 327–336.
34. Matsuo K., Kaun S.S., Gualtieri M. et al. The importance of adenomyosis on a tumor progression and the outcome of the survival of endometrial cancer. Ann. Surg.oncol. 2014; 21 (13): 4246–55.
35. Koshiyama M., Suzuki A., Ozava M. et al. Adenocarcinomas arising from uterine adenomyosis: a report of four cases. Inter J Gynecol Pathol. 2002; 21 (3): 239–245.
36. Kok V.C., Tsai H.J., Su C.F., Li C.K. Risks for ovaries, endometrium, breast, colorectal and other cancers in women with newly diagnosed endometriosis or adenomyosis: a population study. Int. J. Gynecol. Cancer. 2015; 25 (6): 968–76.
